<VariationArchive VariationID="11543" VariationName="NM_003611.3(OFD1):c.2126_2129dup (p.Asn711fs)" VariationType="Duplication" Accession="VCV000011543" Version="12" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2013-05-03" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26582" VariationID="11543">
      <GeneList>
        <Gene Symbol="OFD1" FullName="OFD1 centriole and centriolar satellite protein" GeneID="8481" HGNC_ID="HGNC:2567" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="13714505" stop="13773738" display_start="13714505" display_stop="13773738" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="13752831" stop="13787479" display_start="13752831" display_stop="13787479" Strand="+" />
          </Location>
          <OMIM>300170</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OFD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OFD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003611.3(OFD1):c.2126_2129dup (p.Asn711fs)</Name>
      <CanonicalSPDI>NC_000023.11:13760582:AAGAAAG:AAGAAAGAAAG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="13760582" stop="13760583" display_start="13760582" display_stop="13760583" variantLength="4" positionVCF="13760582" referenceAlleleVCF="G" alternateAlleleVCF="GAAGA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="13778701" stop="13778702" display_start="13778701" display_stop="13778702" variantLength="4" positionVCF="13778701" referenceAlleleVCF="G" alternateAlleleVCF="GAAGA" />
      </Location>
      <ProteinChange>N671fs</ProteinChange>
      <ProteinChange>N571fs</ProteinChange>
      <ProteinChange>N711fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.13778705_13778708dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.13778705_13778708dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.13760586_13760589dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.13760586_13760589dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008872.1" sequenceAccession="NG_008872" sequenceVersion="1" change="g.30874_30877dup">
            <Expression>NG_008872.1:g.30874_30877dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330209.2" sequenceAccession="NM_001330209" sequenceVersion="2" change="c.2006_2009dup">
            <Expression>NM_001330209.2:c.2006_2009dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317138.1" sequenceAccession="NP_001317138" sequenceVersion="1" change="p.Asn671fs">
            <Expression>NP_001317138.1:p.Asn671fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330210.2" sequenceAccession="NM_001330210" sequenceVersion="2" change="c.1706_1709dup">
            <Expression>NM_001330210.2:c.1706_1709dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317139.1" sequenceAccession="NP_001317139" sequenceVersion="1" change="p.Asn571fs">
            <Expression>NP_001317139.1:p.Asn571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003611.3" sequenceAccession="NM_003611" sequenceVersion="3" change="c.2126_2129dup" MANESelect="true">
            <Expression>NM_003611.3:c.2126_2129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003602.1" sequenceAccession="NP_003602" sequenceVersion="1" change="p.Asn711fs">
            <Expression>NP_003602.1:p.Asn711fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003611.2" sequenceAccession="NM_003611" sequenceVersion="2" change="c.2122-2125dupAAGA">
            <Expression>NM_003611.2:c.2122-2125dupAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA121541" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300170.0007" DB="OMIM" />
        <XRef Type="rs" ID="312262890" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003611.3(OFD1):c.2126_2129dup (p.Asn711fs) AND Simpson-Golabi-Behmel syndrome type 2" Accession="RCV000012299" Version="30">
        <ClassifiedConditionList TraitSetID="3149">
          <ClassifiedCondition DB="MedGen" ID="C1846175">Simpson-Golabi-Behmel syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003611.3(OFD1):c.2126_2129dup (p.Asn711fs) AND Orofaciodigital syndrome I" Accession="RCV000033991" Version="4">
        <ClassifiedConditionList TraitSetID="3148">
          <ClassifiedCondition DB="MedGen" ID="C1510460">Orofaciodigital syndrome I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-02-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-02-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-05-03" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16783569</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301367</ID>
          <ID Source="BookShelf">NBK1188</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3148" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3323" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Oral-Facial-Digital Syndrome Type I</ElementValue>
                <XRef ID="NBK1188" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Orofaciodigital syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OFD syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oral-facial-digital syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillon-League-Psaume syndrome (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Orofaciodigital syndrome I</ElementValue>
                <XRef ID="MONDO:0010702" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OFDS 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OFDS I</ElementValue>
                <XRef Type="MIM" ID="311200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Papillon-Leage and Psaume Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OFD1</ElementValue>
                <XRef Type="MIM" ID="311200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4121" />
                <XRef ID="4121" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Oral-facial-digital syndrome type I (OFD1) is usually male lethal during gestation and predominantly affects females. OFD1 is characterized by the following features: Oral (lobulated tongue, tongue nodules, cleft of the hard or soft palate, accessory gingival frenulae, hypodontia, and other dental abnormalities). Facial (widely spaced eyes or telecanthus, hypoplasia of the alae nasi, median cleft or pseudocleft upper lip, micrognathia). Digital (brachydactyly, syndactyly, clinodactyly of the fifth finger; duplicated hallux [great toe]). Kidney (polycystic kidney disease). Brain (e.g., intracerebral cysts, agenesis of the corpus callosum, cerebellar agenesis with or without Dandy-Walker malformation). Intellectual disability (in ~50% of individuals).</Attribute>
                <XRef ID="NBK1188" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301367</ID>
                <ID Source="BookShelf">NBK1188</ID>
              </Citation>
              <XRef ID="2750" DB="Orphanet" />
              <XRef ID="C1510460" DB="MedGen" />
              <XRef ID="MONDO:0010702" DB="MONDO" />
              <XRef Type="MIM" ID="311200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3149" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5917" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Simpson-Golabi-Behmel syndrome type 2</ElementValue>
                <XRef ID="MONDO:0010265" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SGBS2</ElementValue>
                <XRef Type="MIM" ID="300209" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CXORF5</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OFD1</ElementValue>
              </Symbol>
              <XRef ID="79022" DB="Orphanet" />
              <XRef ID="C1846175" DB="MedGen" />
              <XRef ID="MONDO:0010265" DB="MONDO" />
              <XRef Type="MIM" ID="300209" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="97196" SubmissionDate="2013-03-26" DateLastUpdated="2013-05-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_003611.2:c.2122-2125dupAAGA_NBK1188" title="NM_003611.2:c.2122-2125dupAAGA and Oral-Facial-Digital Syndrome Type I" />
        <ClinVarAccession Accession="SCV000057921" DateUpdated="2013-05-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003611.2:c.2122-2125dupAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Oral-Facial-Digital Syndrome Type I</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1188" />
            <XRef DB="OMIM" ID="311200" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32533" SubmissionDate="2020-01-28" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300170.0007_SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (1 family)" title="OFD1, 4-BP DUP, 2122AAGA_SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (1 family)" />
        <ClinVarAccession Accession="SCV000032533" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="16" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 affected males from a Polish family with a phenotype consistent with Simpson-Golabi-Behmel syndrome type 2 (SGBS2; 300209), Budny et al. (2006) identified a 4-bp duplication (2122dupAAGA) in exon 16 of the CXORF5 gene, predicted to introduce a premature stop codon in the CXORF5-1 transcript. Six unaffected obligate female carriers in the family also carried the mutation. The phenotype in this family was consistent with X-linked recessive inheritance and included mental retardation, macrocephaly, and respiratory problems due to ciliary dysfunction. All affected males besides the proband died at an early age.</Attribute>
              <Citation>
                <ID Source="PubMed">16783569</ID>
              </Citation>
              <XRef DB="OMIM" ID="300209" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OFD1" />
          </GeneList>
          <Name>OFD1, 4-BP DUP, 2122AAGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 2122AAGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300170.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32533" TraitType="Disease" MappingType="Name" MappingValue="SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (1 family)" MappingRef="Preferred">
        <MedGen CUI="C1846175" Name="Simpson-Golabi-Behmel syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="97196" TraitType="Disease" MappingType="Name" MappingValue="Oral-Facial-Digital Syndrome Type I" MappingRef="Preferred">
        <MedGen CUI="C1510460" Name="Orofaciodigital syndrome I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

